DHER34:BVMF
Danaher Corporation Bdr
31,71 R$
arrow_downward
−1,37%(−0,44) 1 p
24. apr, 16:56:00 GMT −3 · BRL
search
Kõik sümbolid
1 p
5 p
1 kuu
6 kuud
YTD
1 a
5 a
MAX
| Sümbol | Hind | Muutus | % muutus |
|---|
insights_autoÜksuse DHER34 põhistatistika genereerimine…
Ava
32,04 R$
Kõrge
32,06 R$
Madal
31,67 R$
Turu kapit.
125,45 mld
Keskm. maht
1,76 tuh
Maht
388,00
52 näd kõrgeim
45,99 R$
52 näd madalaim
31,67 R$
Käibivad aktsiad
707,77 mln
Töötajate arv
59 tuh
Uudised
Erinevatest veebiallikatest
MarketBeat
·
19 tunni eest
Argus Issues Pessimistic Forecast for Danaher (NYSE:DHR) Stock Price
AOL.com
·
21 tunni eest
This Stock Is Up Over 52,700% Since Founding. Should Investors Buy After Its 36% Decline?
Yahoo Finance
·
1 päeva eest
Is Danaher (DHR) Now At An Appealing Price After Recent Share Price Weakness
Profiil
Danaher Corporation is an American healthcare company headquartered in Washington, D.C.. It develops products used for advances in biotechnology, life sciences, and diagnostics. The company operates three divisions: biotechnology, which develops products for the development of therapeutics; life sciences, which develops products to identify causes of disease, new therapies, and to test and manufacture new drugs, vaccines and gene editing technologies; and diagnostics, which develops instruments, consumables, and software and services to diagnose diseases. Danaher was founded in 1984 by brothers Steven Rales and Mitchell Rales; it was named after Danaher Creek in Western Montana, where the brothers came up with the idea for the company while fishing.
The company is ranked 180th on the Fortune 500 and 241st on the Forbes Global 2000. Wikipedia
Teave üksuse Danaher Corporation Bdr kohta
AI genereeritud sisu võib sisaldada vigu. Lisateave